Table 2.
Glycocalyx and endothelial dysfunction markers of patients according to selected group
| Healthy controls n = 30 |
Transplant n = 30 |
CKD n = 32 |
Dialysis n = 33 |
p-value | |
|---|---|---|---|---|---|
| PBR (µm) | 2.05 ± 0.3 | 2.06 ± 0.28 | 2.07 ± 0.27 | 2.01 ± 0.35 | 0.89 |
| Hyaluronan (ng/mL) | 23 (8-116) | 57 (14–218) | 79 (11–257) | 137 (16-1414) | < 0.001 |
| Syndecan-1 (ng/mL) | 30 (12–138) | 39 (23–72) | 46 (21–134) | 81 (40–529) | < 0.001 |
| vWF (mIU/mL) | 1685 ± 689 | 2016 ± 653 | 3076 ± 946 | 3920 ± 1755 | < 0.001 |
| VCAM-1 (ng/mL) | 598 (345–1189) | 927 (602–1813) | 1176 (559–3046) | 1479 (737–2900) | < 0.001 |
| uACR (mg/mmol) | 0.4 (0-1.9) | 5 (0–35) | 30 (0-730) | - | 0.002 |